Colitis ulcerosa: nyitott vizsgálatok itt: Belgium
33 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. nov. 10.. Ask the study team whether a trial fits you.
2. fázisToborozResearch participation
An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis
- Where
- La Louviere, Yvoir
- Age
- 18 év and over
- People
- 593 worldwide
- Run by
- Eli Lilly & Co.
See details and how to join2023-507853-13-00EU 2023-507853-13-00Regiszter frissítve: 2026-11-09
2. fázisCsak meghívásosTrial-stage medicine
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
- Where
- Brugge, Gent, Leuven, Roeselare, Sint-Niklaas
- Age
- 18 év and over
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07652294EU 2025-524640-35-00Regiszter frissítve: 2026-11-09
3. fázisToborozTrial-stage medicine
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- Aalst, Brussels, Kortrijk, Leuven, Liège
- Age
- 18 év to 70 év
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086EU 2024-520209-38-00Regiszter frissítve: 2026-11-04
2. fázisToborozTrial-stage medicine
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Where
- Gent, Leuven, Roeselare
- Age
- 18 év to 80 év
- People
- 60 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07483073EU 2025-524112-11-00Regiszter frissítve: 2026-11-04
3. fázisToborozTrial-stage medicine
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Gent, Jette, Leuven
- Age
- 3 év to 64 év
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332EU 2023-509560-16-00Regiszter frissítve: 2026-11-03
3. fázisToborozTrial-stage medicine
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Anderlecht, Bonheiden, Brugge, Gent, Jette, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- 18 év and over
- People
- 644 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07577856EU 2026-525923-26-00Regiszter frissítve: 2026-11-03
2. fázisToborozTrial-stage medicine
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- Where
- Leuven
- Age
- 12 év to 17 év
- People
- 36 worldwide
- Run by
- Pfizer
See details and how to joinNCT05287126EU 2022-500345-25-00Regiszter frissítve: 2026-10-27
2. fázisToborozTrial-stage medicine
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Where
- Brugge, Gent, Leuven, Roeselare, Sint-Niklaas
- Age
- 18 év to 75 év
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07012395EU 2025-521242-26-00Regiszter frissítve: 2026-10-27
3. fázisToborozTrial-stage medicine
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Where
- Brussels, Liège, Sint-Lambrechts-Woluwe
- Age
- 2 év to 17 év
- People
- 120 worldwide
- Run by
- AbbVie
See details and how to joinNCT07071519EU 2024-514695-41-00Regiszter frissítve: 2026-10-27
3. fázisToborozResearch participation
A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis
- Where
- Brussels, Liège, Namur
- Age
- Up to 17 év
- People
- 68 worldwide
- Run by
- Alfasigma S.p.A.
See details and how to join2024-511458-32-00EU 2024-511458-32-00Regiszter frissítve: 2026-10-26
No phaseToborozResearch participation
Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)
- Where
- Leuven
- Age
- 18 év to 65 év
- People
- 99 999 999
- Run by
- KU Leuven
See details and how to joinNCT02421705Regiszter frissítve: 2026-10-22
2/3. fázisToborozTrial-stage medicine
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Where
- Brussels, Edegem, Leuven, Liège
- Age
- 2 év to 17 év
- People
- 120 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT05076175Regiszter frissítve: 2026-10-20
3. fázisToborozTrial-stage medicine
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
- Where
- Brussels, Liège, Namur
- Age
- 8 év to 18 év
- People
- 80 worldwide
- Run by
- Alfasigma S.p.A.
See details and how to joinNCT06865417Regiszter frissítve: 2026-10-20
3. fázisToborozTrial-stage medicine
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Yvoir
- Age
- 16 év to 80 év
- People
- 751 worldwide
- Run by
- Sanofi
See details and how to joinNCT07185009Regiszter frissítve: 2026-10-16
1. fázisToborozTrial-stage medicine
An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
- Where
- Leuven, Roeselare
- Age
- 18 év to 60 év
- People
- 25 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07665723EU 2025-524060-38-00Regiszter frissítve: 2026-10-16
3. fázisToborozTrial-stage medicine
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Where
- Liège, Sint-Lambrechts-Woluwe
- Age
- 2 év to 17 év
- People
- 70 worldwide
- Run by
- Takeda
See details and how to joinNCT06405087EU 2023-508804-39-00Regiszter frissítve: 2026-10-09
3. fázisToborozTrial-stage medicine
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Where
- Brussels, Edegem, Ghent, Leuven
- Age
- 2 év to 19 év
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT04844606Regiszter frissítve: 2026-10-07
No phaseToborozResearch participation
Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowel Disease in Belgium
- Where
- Anderlecht, Bonheiden, Genk, Ghent, Kortrijk, Liège, Lodelinsart, Roeselare, Sint-Niklaas, Tournai
- Age
- 18 év and over
- People
- 280
- Run by
- AbbVie
See details and how to joinNCT06581042Regiszter frissítve: 2026-09-23
2. fázisToborozTrial-stage medicine
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Where
- Leuven, Liège
- Age
- 18 év to 80 év
- People
- 80 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06636656EU 2023-509544-10-00Regiszter frissítve: 2026-08-21
4. fázisToborozResearch participation
Model-informed precision dosing during infliximab rescue therapy for patients with steroid-refractory acute severe ulcerative colitis: an exploratory study (the IGNITE study)
- Where
- Leuven
- Age
- 18 év and over
- People
- 13
- Run by
- UZ Leuven
See details and how to join2023-503509-12-00EU 2023-503509-12-00Regiszter frissítve: 2026-08-11
3. fázisToborozTrial-stage medicine
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Where
- Liège, Sint-Lambrechts-Woluwe
- Age
- 2 év to 17 év
- People
- 70 worldwide
- Run by
- Takeda
See details and how to joinNCT06100289EU 2023-503188-40-00Regiszter frissítve: 2026-08-03
2. fázisToborozResearch participation
A Phase 2a Study of the Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
- Where
- Leuven
- Age
- 18 év and over
- People
- 70 worldwide
- Run by
- Odyssey Therapeutics Inc.
See details and how to join2024-520201-39-00EU 2024-520201-39-00Regiszter frissítve: 2026-07-31
2/3. fázisToborozResearch participation
A phase 2/3, multicenter, randomized, double-blind study to evaluate the efficacy, safety, pharmacokinetics and pharmacodynamics of oral ozanimod (RPC1063) in pediatric subjects with moderately to severely active ulcerative colitis with an inadequate response to conventional therapy.
- Where
- Edegem, Jette, Leuven, Liège
- Age
- Up to 17 év
- People
- 62 worldwide
- Run by
- Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-509248-86-00EU 2023-509248-86-00Regiszter frissítve: 2026-07-22
2. fázisToborozResearch participation
A Phase 2 Platform Study to Evaluate Therapies for Inflammatory Bowel Disease
- Where
- Bonheiden, Edegem, Leuven
- Age
- 18 év and over
- People
- 54 worldwide
- Run by
- Mirador Therapeutics Inc.
See details and how to join2025-522001-38-00EU 2025-522001-38-00Regiszter frissítve: 2026-07-20
No phaseToborozResearch participation
Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context
- Where
- Bonheiden
- Age
- 16 év and over
- People
- 100
- Run by
- Imelda GI Clinical Research Center
See details and how to joinNCT07621783Regiszter frissítve: 2026-06-02
Minden vizsgálat (Colitis ulcerosa) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.